SURVYR

UNH

UnitedHealth Group Incorporated
$410.39
−$0.31 (0.08%)Oct 27 close
Health CareS&P 500 CompareTechnicals
1M3M6M1Y2Y
-28%-16%-3%+9%+22%Oct 2025Oct 2026Apr 202652w low $255.97
UNHSPY
Wall St. Highest PT $531.00 (+29.4%) Wall St. Avg PT $476.64 (+16.1%)
$256$329$401$474$547POC $402Hi $531Avg $477
Underwater Drawdown %Max DD -28.6%Current -5.4%
0.0%-28.6%
Relative Strength vs SPY+1.6% vs SPYOutperforming
+30%0%-30%
1W
−$8.87 (2.12%)
1M
+$33.80 (8.98%)
3M
−$15.78 (3.70%)
6M
+$47.93 (13.23%)
YTD
+$86.68 (26.78%)
1Y
+$53.90 (15.12%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Wall Street analyst consensus
SellHoldStrong Buy
Buy
26 analysts · mean score 1.62
1 = Strong Buy · 5 = Sell
Strong Buy623%
Buy1558%
Hold519%
Underperform00%
Sell00%
Wall Street consensus
Analyst price targets
Current price$410.39
Average target$476.64
+$66.25 (+16.1%) upsideaverage target vs current price
CurrentAverageMedian
Low$380.00
Median$490.00
High$531.00
12-month Wall Street target range
Recent analyst rating changes · 30
Reiterated
2026-10-27 · Wells Fargo reiterated Overweight on UNH
Reiterated
2026-10-27 · Morgan Stanley reiterated Overweight on UNH
Reiterated
2026-10-22 · Mizuho reiterated Outperform on UNH
Reiterated
2026-10-20 · RBC Capital reiterated Outperform on UNH
Reiterated
2026-10-16 · Bernstein reiterated Outperform on UNH
Reiterated
2026-10-16 · JP Morgan reiterated Overweight on UNH
All analyst rating changes ›

Third-party ratings, not SURVYR.'s views.

Key stats & company

Market value$368.4B
P/E (last 12 months)26.4
P/E (next 12 months, estimated)17.6
52-week range$255.97 – $461.62
Revenue growth (latest quarter vs a year ago)-0.4%
Dividend yield2.26%
Analyst consensusBuy (25)
Average analyst price target$476.64 (+16%)

What they do

UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers.

Healthcare · Healthcare Plans
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

Momentum
40th percentile in sector
C
12-1 return: +10.3%
Percentile within its GICS sector across the S&P 1500.
Growth
9th percentile in sector
D-
Revenue growth (YoY): -0.4%
Percentile within its GICS sector across the S&P 1500.
Value
57th percentile in sector
B-
Forward E/P: 5.8% · EBITDA/EV: 7.1%
Percentile within its GICS sector across the S&P 1500.
Profitability
50th percentile in sector
C+
Profit margin: +3.5% · Return on equity: +15.8%
Percentile within its GICS sector across the S&P 1500.
Revisions
Not enough data yet
–
EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth
Outside this model's universe or screens
 Momentum Top 15
ranked 213 of 499 · 12-month momentum 15.1%
 Momentum Blend
Not in the current book
 New Highs Growth
Outside this model's universe or screens
 SURVYR. Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
 SURVYR. Physical AI Grid & Power
Outside this model's universe or screens
 SURVYR. Long Book
Not in the current book

Earnings & events

UNH earningsNext report in 77 days
Next report
Tue Jan 12, 2027Before the open
EPS consensus$2.26 range $2.05–$2.62
Revenue consensus$112.5B 18 analysts
Last 4 quarters · EPS vs estimate
Oct 13, 2026$4.69est $4.14+13.3%Above estimates
Jul 16, 2026$6.38est $4.92+29.8%Above estimates
Apr 21, 2026$7.23est $6.60+9.5%Above estimates
Jan 27, 2026$2.11est $2.11+0.2%In line with estimates

In line = within 1% of the estimate.

Source: Yahoo Finance · refreshed 2026-10-27 18:04:49 ET
25-0125-0425-0725-1026-0126-0426-0726-100.007.29
EstimateActual (beat)Actual (miss)

Quarterly revenue

QuarterRevenueYoY
2026-06-30$112.0B+0.4%
2026-03-31$111.7B–
2025-12-31$113.2B–
2025-09-30$113.2B–
2025-06-30$111.6B–

Recent dividends

2026-09-14: $2.320 · 2026-06-15: $2.320 · 2026-03-09: $2.210 · 2025-12-08: $2.210 · 2025-09-15: $2.210 · 2025-06-16: $2.210 · 2025-03-10: $2.100 · 2024-12-09: $2.100

News & catalysts

More news
State Street SPDR Dow Jones (DIA) Sells Goldman Sachs and Caterpillar on Oct. 23
GuruFocus.com · 12h ago
How Much Should This Move Change Your View Of Centene Stock?
Trefis · Oct 26
Abbott Laboratories vs. UnitedHealth: Does Health Innovation or Health Insurance Make for a Better Stock to Buy?
Nasdaq · Oct 24
Noteworthy Friday Option Activity: UNH, HIMS, VEL
Nasdaq · Oct 23
UnitedHealth's Earnings Jumped 60%. Is the Comeback Stock a Buy, Sell, or Hold?
Nasdaq · Oct 21
Rating changes
Reiterated
2026-10-27 · Wells Fargo reiterated Overweight on UNH
Reiterated
2026-10-27 · Morgan Stanley reiterated Overweight on UNH
Reiterated
2026-10-22 · Mizuho reiterated Outperform on UNH
Reiterated
2026-10-20 · RBC Capital reiterated Outperform on UNH
Reiterated
2026-10-16 · Bernstein reiterated Outperform on UNH
Reiterated
2026-10-16 · JP Morgan reiterated Overweight on UNH

Third-party analyst actions, not SURVYR.'s views. All rating changes

Insider trades
Conway Patrick Hugh
Chief Executive Officer, Optum · 2026-08-21
Sell
$455.9K
Conway Patrick Hugh
Chief Executive Officer, Optum · 2026-08-05
Sell
$205.0K
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–

Stats refreshed 2026-10-27 18:04:49 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Coteau 0.9 · Oct 21, 2026